In non-small cell lung cancer (NSCLC) patients undergoing classical radiotherapy/chemotherapy regimen, showed that I-CRP administration increased leukocyte counts and improved patients’ quality of life (Franco-Molina et al., 2008). Here, CRP is linked to non-small cell lung carcinoma.